MEAKSS, a synthetic peptide, is emerging as a promising agent for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates remarkable neuroprotective effects by modulating key cellular pathways involved in neuronal function. Studies suggest that MEAKSS can enhance synaptogenesis, {reduceneurotoxicity, and augment cognit